Design Therapeutics develops genetic medicines for serious diseases. Its main services and products include drug discovery and clinical-stage therapies for patients with inherited disorders and healthcare providers.
Design Therapeutics products and services overview:
Revenue: ~$0 million
Employees: 110
Headquarters: Carlsbad, United States (USA)
Design Therapeutics is one of the...
Design Therapeutics is a company listed under the stock ticker DSGN (US).
View the org chart displaying its 27 main executives
Create your alert
to follow the executive moves at Design Therapeutics.
Design Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.